The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Abstract
OBJECTIVE—To estimate the prevalence of and the cardiovascular risk associated with the metabolic syndrome using the new definition proposed by the World Health Organization (WHO). RESEARCH DESIGN AND METHODS—A total of 4,483 subjects aged 35–70 years participating in a large family study of type 2 diabetes in Finland and Sweden (the Botnia study) were included in the analysis of cardiovascular risk associated with the metabolic syndrome. In subjects who had type 2 diabetes (n = 1,697), impaired fasting glucose (IFG)/impaired glucose tolerance (IGT) (n = 798), or insulin-resistance with normal glucose tolerance (NGT) (n = 1,988), the metabolic syndrome was defined as presence of at least two of the following risk factors: obesity, hypertension, dyslipidemia, or microalbuminuria. Cardiovascular mortality was assessed in 3,606 subjects with a median follow-up of 6.9 years. RESULTS—In women and men, respectively, the metabolic syndrome was seen in 10 and 15% of subjects with NGT, 42 and 64% of those with IFG/IGT, and 78 and 84% of those with type 2 diabetes. The risk for coronary heart disease and stroke was increased threefold in subjects with the syndrome (P < 0.001). Cardiovascular mortality was markedly increased in subjects with the metabolic syndrome (12.0 vs. 2.2%, P < 0.001). Of the individual components of the metabolic syndrome, microalbuminuria conferred the strongest risk of cardiovascular death (RR 2.80; P = 0.002). CONCLUSIONS—The WHO definition of the metabolic syndrome identifies subjects with increased cardiovascular morbidity and mortality and offers a tool for comparison of results from different studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The MS has been associated with incident CHD and CHD mortality, [5][6][7][8][9][10][11]”
From Diabetes, the Metabolic Syndrome, and Angiographic Progression of Coronary Arterial Disease in Postmenopausal Women (2006) · cites this paper as [7]
In the citing paper
“[Statement]Metabolic syndrome is a condition that poses a high risk for the development of cardiovascular disease (Evidence level: E-1b).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [324]
In the citing paper
“Conditions, such as metabolic syndrome, that involve the clustering of multiple risk factors have been shown to increase the risk of cardiovascular diseases in epidemiological studies323–326) and meta-analyses327), as well as in CIRCS study78), the Tanno and Sobetsu study328) and the Hisayama study317).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [324]
In the citing paper
“Metabolic syndrome is significant because it is a high risk of ASCVD even if the levels of hyperglycemia, dyslipidemia and elevated blood pressure are relatively mild323–327).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [324]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,555
Cardiovascular Survey Methods.
Rose, G., & Blackburn, H. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1335_2 · Cited by 3,090
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A.-M., & Pająk, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,260
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Kaplan, N. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.7.1514 · Cited by 1,672
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X)
Haffner, S. M., Valdez, R. A., Hazuda, H. P., Mitchell, B. D., Morales, P. A., & D, M. P. S. M. (1992) · Diabetes · doi:10.2337/diab.41.6.715 · Cited by 1,234
The Association of Microalbuminuria and Mortality in Non—Insulin-Dependent Diabetes Mellitus
Dinneen, S. F. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.13.1413 · Cited by 884
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Bonora, E., Kiechl, S. J., Willeit, J., Oberhollenzer, F., Egger, G., Targher, G., Alberiche, M., Bonadonna, R. C., & Muggeo, M. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1643 · Cited by 833
The homeostasis model in the San Antonio Heart Study.
Haffner, S. M., Miettinen, H., & Stern, M. P. (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1087 · Cited by 788
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
Tuomi, T., Carlsson, A., Li, H., Isomaa, B., Miettinen, A., Nilsson, A.-L., Nissén, M., Ehrnström, B. O., Forsén, B., Snickars, B., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.1.150 · Cited by 504
Self-citationRole of fatty acids in the pathogenesis of insulin resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diabetes.46.1.3 · Cited by 479
Borch‐Johnsen, K., Feldt‐Rasmussen, B., Strandgaard, S., Schroll, M., & Jensen, J. S. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.8.1992 · Cited by 441
Groop, L., Forsblom, C. M., Lehtovirta, M., Tuomi, T., Karanko, S., Nissén, M., Ehrnstrom, B. O., Forsén, B., Isomaa, B., Snickars, B., et al. (1996) · Diabetes · doi:10.2337/diab.45.11.1585 · Cited by 384
Self-citationMykkänen, L. M., Zaccaro, D. J., Wagenknecht, L. E., Robbins, D. C., Gabriel, M., & Haffner, S. M. (1998) · Diabetes · doi:10.2337/diabetes.47.5.793 · Cited by 379
Prospective analysis of the insulin-resistance syndrome (syndrome X)
Haffner, S. M., Valdez, R. A., Hazuda, H. P., et al. (1992) · Diabetes · doi:10.2337/diabetes.41.6.715 · Cited by 273
Abdominal Obesity and the Metabolic Syndrome
Björntorp, P. (1992) · Annals of Medicine · doi:10.3109/07853899209166997 · Cited by 233
Groop, L., Ekstrand, A., Forsblom, C. M., Wid�n, E., Groop, P., Teppo, A.-M., & Eriksson, J. G. (1993) · Diabetologia · doi:10.1007/bf00404074 · Cited by 233
Self-citationHyperinsulinemic Microalbuminuria
Kuusisto, J., Mykkänen, L., Pyörälä, K., & Laakso, M. (1995) · Circulation · doi:10.1161/01.cir.91.3.831 · Cited by 230
Jensen, J. S., Borch‐Johnsen, K., Jensen, G. B., & Feldt‐Rasmussen, B. (1995) · Clinical Science · doi:10.1042/cs0880629 · Cited by 220
Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects
Rantala, A. O., Kauma, H., Lilja, M., Savolainen, M. J., Reunanen, A., & Kesäniemi, Y. A. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00429.x · Cited by 211
Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect.
Lehto, M. J., Tuomi, T., Mahtani, M. M., Widén, E., Forsblom, C. M., Sarelin, L., Gullström, M., Isomaa, B., Lehtovirta, M., Hyrkkö, A., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119199 · Cited by 198
Self-citationLehto, S., Rönnemaa, T., Pyörälà, K., & Laakso, M. (2000) · Diabetologia · doi:10.1007/s001250050023 · Cited by 192
Js, Y. (1999) · PubMed · Cited by 131
Studien ueber das Hypertonie-Hyperglyka "mie-Hyperurika" miesyndrom
Kylin, E. (1923) · Medical Entomology and Zoology · Cited by 118
Familial components of the multiple metabolic syndrome: the ARIC Study
Liese, A. D., Mayer‐Davis, E. J., Tyroler, H. A., DAVIS, C. E., Keil, U., Schmidt, M. I., Brancati, F. L., & HEISS, G. M. (1997) · Diabetologia · doi:10.1007/s001250050775 · Cited by 114
Groop, L., Forsblom, C. M., Lehtovirta, M., et al. (1996) · Diabetes · doi:10.2337/diabetes.45.11.1585 · Cited by 99
Self-citation'Metabolic Syndrome' in a Middle-Aged Finnish Population
Vanhala, M. J., Kumpusalo, E. A., Pitkäjärvi, T., & Takala, J. K. (1997) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679700400410 · Cited by 51
New Insights into Lipid Metabolism in Non-insulin-dependent Diabetes Mellitus
Taskinen, M., Lahdenperä, S., & Syvänne, M. (1996) · Annals of Medicine · doi:10.3109/07853899608999090 · Cited by 48
Self-citationYki‐Järvinen, H. (1992) · Endocrine Reviews · doi:10.1210/er.13.3.415 · Cited by 47
McCarthy, M. I., Cassell, P., Tran, T., Mathias, L., Hart, L. M. ‘., Maassen, J. A., Snehalatha, C., Ramachandran, A., Viswanathan, M., & Hitman, G. A. (1996) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199605)13:5 · Cited by 41
??Metabolic syndrome?? in a middle-aged Finnish population
Vanhala, M. J., Kumpusalo, E. A., rvi, T. K. P. J., & Takala, J. K. (1997) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199708000-00010 · Cited by 41
Zavaroni, I., BONINI, L., Gasparini, P., Zuccarelli, A., Dall’Aglio, E., BARILLI, L., Cioni, F., Strata, A., & Reaven, G. M. (1996) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1996.23849000.x · Cited by 36
Jensen, J. S., Borch‐Johnsen, K., Feldt‐Rasmussen, B., Appleyard, M., & JENSEN, G. F. (1997) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679700400208 · Cited by 34
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7
Flagged first, then by citations
Research works printed but not linked: 2
- Descovich GC, Benassi B, Cancelli V, D’Addato S, De Simone, Dormi A: An epidemic view of the plurimetabolic syndrome. In Diabetes, Obesity and Hyperlipidemias. V. The Plurimetabolic Syndrome Crepaleli G, Tiengo A, Manzato E, Eds. Amsterdam, Netherlands, Elsevier Science, 1993, p. 31–39
- Bouchard C, Perusse L: Genetics of causes and manifestations of the metabolic syndrome. In Diabetes, obesity and hyperlipidemia: V. The plurimetabolic syndrome Crepaldi G, Tiengo A, Manzato E, Eds., Amsterdam, Elsevier Science, 1993, p. 67–74
Cited by
Sorted by citations
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,317
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Metadata
- Authors
- Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L.
- Affiliations
- Department of Internal Medicine, Jakobstad Hospital, Jakobstad, Finland
- Lund University (SE)
- Helsinki University Hospital (FI)
- Närpes Health Center, Närpes
- Vasa Health Center
- Vaasa Central Hospital (FI)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2001-04-01
- Volume
- 24
- Issue
- 4
- Pages
- 683-689
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W1986349550
- Cited by
- 4,760
- References
- 36
- Citations by year
- 2026: 27 · 2025: 70 · 2024: 93 · 2023: 88 · 2022: 123 · 2021: 132 · 2020: 128 · 2019: 137 · 2018: 139 · 2017: 153 · 2016: 185 · 2015: 198 · 2014: 218 · 2013: 211 · 2012: 222
- FWCI
- 100.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Svenska Läkaresällskapet
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- metabolic syndrome, cardiovascular mortality, cardiovascular morbidity, type 2 diabetes, impaired fasting glucose, impaired glucose tolerance, insulin resistance, microalbuminuria, coronary artery disease, stroke, obesity, hypertension, dyslipidemia, WHO definition
- MeSH terms
- Adult, Age Factors, Aged, Albuminuria, Blood Glucose, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Type 2, Family, Female, Finland, Glycated Hemoglobin, Humans, Hyperlipidemias, Hypertension, Insulin Resistance, Cholesterol, HDL, Male, Middle Aged, Morbidity, Obesity, Risk Factors, Sex Factors, Sweden, Triglycerides, Prevalence, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review